Ace Pharm is a specialized pharmaceutical company focused on the development, manufacturing, and global distribution of niche and essential medicines. Committed to addressing unmet medical needs and improving patient access to high-quality treatments, Ace Pharm operates with a strong emphasis on research, quality assurance, and regulatory compliance. The company often engages in the licensing and supply of registered and unregistered medicines, catering to specific patient populations and healthcare provider requirements.
The headquarters houses key corporate functions including executive management, research and development oversight, regulatory affairs, quality assurance, and international business development.
A modern pharmaceutical facility designed for GMP (Good Manufacturing Practice) compliance, likely incorporating advanced laboratories, controlled environment manufacturing spaces, and administrative offices.
The work culture at Ace Pharm's headquarters is characterized by a strong commitment to scientific rigor, precision, ethical conduct, and collaboration. Employees are typically focused on patient safety and product quality.
The Zeewolde headquarters is strategically important for Ace Pharm's operations within the European Union, facilitating access to regulatory bodies, research institutions, and key distribution channels.
Ace Pharm primarily serves markets across Europe, with a growing interest in expanding its reach to other international territories through strategic partnerships and licensing agreements. Its global functions include international sourcing of active pharmaceutical ingredients (APIs), management of global supply chains for niche products, pharmacovigilance, and ensuring compliance with varying international regulatory standards for medicinal products.
Schepenveld 41
Zeewolde
Flevoland
Netherlands
Address: One Kendall Square, Bldg 200, Cambridge, MA 02139, USA (Illustrative)
To facilitate partnerships with US-based research institutions, manage FDA regulatory interactions, and explore market access opportunities in North America for Ace Pharm's portfolio.
Address: 1 Biopolis Drive, Singapore 138622 (Illustrative)
To expand Ace Pharm's footprint in key Asian markets, navigate diverse regulatory environments, and support regional partners in providing access to specialized medicines.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ace Pharmaceuticals' leadership includes:
Ace Pharmaceuticals has been backed by several prominent investors over the years, including:
Over the past year, Ace Pharm has focused on strengthening its operational leadership. There have been no major publicly announced executive departures, while key internal roles may have seen advancements. (Illustrative summary as specific public news is limited for private companies).
Discover the tools Ace Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ace Pharm (based on ace-pharm.nl) likely uses a common corporate email format. Based on typical Dutch company conventions and the Managing Director's name, a probable format is [first_initial_or_first_name].[last_name]@ace-pharm.nl.
[first_initial].[last_name]@ace-pharm.nl (e.g., j.popma@ace-pharm.nl) or [first_name].[last_name]@ace-pharm.nl
Format
jw.popma@ace-pharm.nl (example based on Managing Director Jan Willem Popma)
Example
80%
Success rate
Pharma Generic News Wire • November 10, 2023
Ace Pharm today announced the successful renewal of its Good Manufacturing Practice (GMP) certification for its manufacturing and development facility in Zeewolde, Netherlands, following a comprehensive inspection by regulatory authorities. This reaffirms the company's commitment to the highest quality standards in pharmaceutical production. (Illustrative news)...more
European Journal of Orphan Drugs • September 05, 2023
Ace Pharm has submitted an application to the European Medicines Agency (EMA) seeking orphan drug designation for its investigational compound AP-021, for the treatment of a rare metabolic disorder. This marks a significant step in its development program for underserved patient populations. (Illustrative news)...more
Global Pharma Partnerships Review • June 22, 2023
Ace Pharm has entered into an exclusive licensing agreement with a European biotech firm to develop and commercialize a novel paediatric formulation for an existing essential medicine, aiming to improve dosing accuracy and acceptability for young children. (Illustrative news)...more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ace Pharmaceuticals, are just a search away.